Showing 1171-1180 of 1236 results for "".
- Chinese Biotechnology Company Unveils Landmark Regenerative Aesthetic Medicine Innovationhttps://modernaesthetics.com/news/chinese-biotechnology-company-unveils-landmark-regenerative-aesthetic-medicine-innovation/2475368/Shanghai Moyom Biotechnology Co., Ltd. Announced the introduction of its new regenerative aesthetic product, Aphranel MagiCCrystal CaHA Filler, at an international event held at the Grand Halls on Shanghai’s Bund Themed “APHRANEL: Code Breaker, World Maker.” Aphranel MagiCCrystal CaHA Fil
- AVAVA Receives FDA Clearance for Acne Scar Treatment on All Skin Types Using Focal Point Technologyhttps://modernaesthetics.com/news/avava-receives-fda-clearance-for-acne-scar-treatment-on-all-skin-types-using-focal-point-technology/2475350/The U.S. Food and Drug Administration (FDA) has cleared AVAVA’s Focal Point Technology™ for the treatment of acne scars, marking a significant milestone in energy-based skin therapy. The technology, developed by Boston-based AVAVA, is now indicated for acne scarring in all Fitzpatrick skin types
- Closing the Healthcare Gender Gap as a Key to Optimize Female Longevityhttps://modernaesthetics.com/news/closing-the-healthcare-gender-gap-as-a-key-to-optimize-female-longevity/2473748/"The story of women's struggle for equality belongs to no single feminist nor to any one organization but to the collective efforts of all who care about human rights." —Gloria Steinem The United Nations has declared the theme for this year’s International
- Report: Regenerative Aesthetics Exosome Market Poised for Growth Through 2031https://modernaesthetics.com/news/report-regenerative-aesthetics-exosome-market-poised-for-growth-through-2031/2473722/The global regenerative aesthetics exosome products market is projected to experience a compound annual growth rate (CAGR) of 35.5% from 2024 to 2031, according to a report from InsightAce Analytic. Exosome-based therapies with applications in skin reju
- ASDS Abstract Highlights Potential of ALA-PDThttps://modernaesthetics.com/news/asds-abstract-highlights-potential-of-ala-pdt/2473704/Photodynamic therapy (PDT) with aminolevulonic acid (ALA) was the topic of the top 10 abstract “Fine Wrinkles and the Art of Light,” presented by Luke Horton, MD, at the 2024 American Society for Dermatologic Surgery (ASDS) Annual Meeting. Dr. Horton performed a study along
- New Research Uncovers Breakthrough in Tissue Engineering Using Bacteriahttps://modernaesthetics.com/news/new-research-uncovers-breakthrough-in-tissue-engineering-using-bacteria/2473654/New research from the Technical University of Denmark uncovered new ground in tissue engineering and cell therapy by harnessing the healing power of bacteria. The study was published in the journal Bioactive Materials and details a new biopolymer, Pantoan Methacrylate (PAMA), with muscle regenera
- Crown Laboratories, Revance Announce Entry Into Merger Agreementhttps://modernaesthetics.com/news/crown-laboratories-revance-announce-entry-into-merger-agreement/2473649/Crown Laboratories, Inc., a privately held, global innovative leader in the skincare industry, and Revance Therapeutics, Inc., a biotechnology company aimed at setting the new standard in healthcare with innovative aesthetic and therapeutic offerings, announced a merger agreement pursuant to whic
- L’Oréal Eyes Aesthetics Market with Acquisition of Minority Stake in Galdermahttps://modernaesthetics.com/news/loreal-eyes-aesthetics-market-with-acquisition-of-galderma/2473646/Major beauty brand L’Oréal announced the acquisition of a 10% stake in Galderma, a Swiss pharmaceutical company. The two companies have agreed to work towards a strategic scientific partnership that will leverage the undisputed expertise of both companies, according to a press releas
- Evolus Expands Global Footprint with Introduction of Treatment in Australiahttps://modernaesthetics.com/news/evolus-expands-global-footprint-with-introduction-of-treatment-in-australia/2473641/The performance beauty company, Evolus, has begun operations in Australia with the launch of Nuceiva, a prabotulinumtoxinA. Nuceiva is approved by the Therapeutic Goods Administration (TGA) for the temporary improvement in the appearance of moderate to severe glabella lines in adul
- DefenAge Skincare Launches New Patented Skin Regeneration Technologyhttps://modernaesthetics.com/news/defenage-skincare-launches-new-patented-skin-regeneration-technology/2473630/DefenAge Skincare announced a new skin regeneration technology with the acquisition of a new patent using a regenerative approach for skin care and wound healing. The company says the cutting-edge technology is now available for licensing and product development partnerships, presenting an unpara